Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.

Journal of drugs in dermatology : JDD

Volumn 5, Issue 4, 2006, Pages 328-332

  Andres, Philippe ^a   Poncet, Michel ^a   Farzaneh, Sidou ^a   Soto, Pascale ^a  

^a Galderma R and D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; COSMETIC; DRUG DERIVATIVE;

ADULT; ARTICLE; ATROPHY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN; SKIN DISEASE; TIME; TREATMENT OUTCOME; VISUAL SYSTEM FUNCTION;

ADMINISTRATION, CUTANEOUS; ADULT; ATROPHY; CLOBETASOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HAIR PREPARATIONS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; OCULAR PHYSIOLOGY; PITUITARY-ADRENAL SYSTEM; PSORIASIS; SCALP DERMATOSES; SKIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748902854     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)